OPRK1-Tango Citations (3)
Originally described in: PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome.Kroeze WK, Sassano MF, Huang XP, Lansu K, McCorvy JD, Giguere PM, Sciaky N, Roth BL Nat Struct Mol Biol. 2015 May;22(5):362-9. doi: 10.1038/nsmb.3014. Epub 2015 Apr 20. PubMed Journal
Articles Citing OPRK1-Tango
| Articles |
|---|
| Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine. Kaski SW, White AN, Gross JD, Trexler KR, Wix K, Harland AA, Prisinzano TE, Aube J, Kinsey SG, Kenakin T, Siderovski DP, Setola V. J Pharmacol Exp Ther. 2019 Nov;371(2):487-499. doi: 10.1124/jpet.118.255661. Epub 2019 Sep 6. PubMed |
| Functional Characterization of Spinocerebellar Ataxia Associated Dynorphin A Mutant Peptides. Lieb A, Thaler G, Fogli B, Trovato O, Posch MA, Kaserer T, Zangrandi L. Biomedicines. 2021 Dec 11;9(12). pii: biomedicines9121882. doi: 10.3390/biomedicines9121882. PubMed |
| Functional Characterization of Sodium Channel Inhibitors at the Delta-Opioid Receptor. Mohamud AO, Zeghal M, Patel S, Laroche G, Blgacim N, Giguere PM. ACS Omega. 2022 May 12;7(20):16939-16951. doi: 10.1021/acsomega.1c07226. eCollection 2022 May 24. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.